nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ABCC10—Cyclosporine—psoriasis	0.0531	0.0792	CbGbCtD
Paclitaxel—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0391	0.0584	CbGbCtD
Paclitaxel—ABCB11—Cyclosporine—psoriasis	0.0288	0.0431	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—psoriasis	0.0281	0.0419	CbGbCtD
Paclitaxel—CYP19A1—Betamethasone—psoriasis	0.0265	0.0395	CbGbCtD
Paclitaxel—CYP2C8—Tazarotene—psoriasis	0.026	0.0389	CbGbCtD
Paclitaxel—CYP3A5—Beclomethasone—psoriasis	0.0252	0.0376	CbGbCtD
Paclitaxel—ABCC1—Cyclosporine—psoriasis	0.0205	0.0306	CbGbCtD
Paclitaxel—ABCC2—Mycophenolate mofetil—psoriasis	0.02	0.0299	CbGbCtD
Paclitaxel—ABCB11—Dexamethasone—psoriasis	0.019	0.0284	CbGbCtD
Paclitaxel—CYP1B1—Dexamethasone—psoriasis	0.019	0.0284	CbGbCtD
Paclitaxel—ABCG2—Mycophenolate mofetil—psoriasis	0.0181	0.027	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—psoriasis	0.0157	0.0234	CbGbCtD
Paclitaxel—CYP19A1—Dexamethasone—psoriasis	0.0154	0.023	CbGbCtD
Paclitaxel—ABCC2—Cyclosporine—psoriasis	0.0152	0.0226	CbGbCtD
Paclitaxel—ABCG2—Hydrocortisone—psoriasis	0.0145	0.0217	CbGbCtD
Paclitaxel—ABCG2—Cyclosporine—psoriasis	0.0137	0.0205	CbGbCtD
Paclitaxel—CYP2C8—Cholecalciferol—psoriasis	0.0111	0.0166	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—psoriasis	0.0108	0.0162	CbGbCtD
Paclitaxel—CYP3A7—Hydrocortisone—psoriasis	0.0107	0.016	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0107	0.016	CbGbCtD
Paclitaxel—CYP3A7—Cyclosporine—psoriasis	0.0101	0.0151	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0101	0.0151	CbGbCtD
Paclitaxel—CYP3A5—Mycophenolate mofetil—psoriasis	0.01	0.015	CbGbCtD
Paclitaxel—ABCC2—Dexamethasone—psoriasis	0.00999	0.0149	CbGbCtD
Paclitaxel—CYP2C8—Mycophenolate mofetil—psoriasis	0.00964	0.0144	CbGbCtD
Paclitaxel—ABCG2—Dexamethasone—psoriasis	0.00903	0.0135	CbGbCtD
Paclitaxel—CYP3A4—Calcitriol—psoriasis	0.00875	0.0131	CbGbCtD
Paclitaxel—CYP3A5—Hydrocortisone—psoriasis	0.00805	0.012	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—psoriasis	0.00803	0.012	CbGbCtD
Paclitaxel—CYP2C9—Cholecalciferol—psoriasis	0.00775	0.0116	CbGbCtD
Paclitaxel—CYP2C8—Hydrocortisone—psoriasis	0.00774	0.0115	CbGbCtD
Paclitaxel—CYP3A5—Cyclosporine—psoriasis	0.0076	0.0113	CbGbCtD
Paclitaxel—CYP2C8—Cyclosporine—psoriasis	0.00731	0.0109	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—psoriasis	0.00726	0.0108	CbGbCtD
Paclitaxel—CYP3A4—Methoxsalen—psoriasis	0.00681	0.0102	CbGbCtD
Paclitaxel—CYP3A7—Dexamethasone—psoriasis	0.00667	0.00995	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00667	0.00995	CbGbCtD
Paclitaxel—ABCB1—Mycophenolate mofetil—psoriasis	0.00653	0.00974	CbGbCtD
Paclitaxel—ABCB1—Betamethasone—psoriasis	0.0056	0.00835	CbGbCtD
Paclitaxel—ABCB1—Prednisolone—psoriasis	0.00552	0.00824	CbGbCtD
Paclitaxel—ABCB1—Hydrocortisone—psoriasis	0.00524	0.00781	CbGbCtD
Paclitaxel—ABCB1—Prednisone—psoriasis	0.00522	0.00778	CbGbCtD
Paclitaxel—CYP2C9—Cyclosporine—psoriasis	0.0051	0.0076	CbGbCtD
Paclitaxel—CYP3A5—Dexamethasone—psoriasis	0.005	0.00747	CbGbCtD
Paclitaxel—ABCB1—Cyclosporine—psoriasis	0.00495	0.00738	CbGbCtD
Paclitaxel—CYP2C8—Dexamethasone—psoriasis	0.00481	0.00718	CbGbCtD
Paclitaxel—CYP3A4—Cholecalciferol—psoriasis	0.00451	0.00673	CbGbCtD
Paclitaxel—CYP3A4—Mycophenolate mofetil—psoriasis	0.00391	0.00583	CbGbCtD
Paclitaxel—CYP3A4—Triamcinolone—psoriasis	0.00391	0.00583	CbGbCtD
Paclitaxel—CYP2C9—Dexamethasone—psoriasis	0.00336	0.00501	CbGbCtD
Paclitaxel—CYP3A4—Betamethasone—psoriasis	0.00335	0.00501	CbGbCtD
Paclitaxel—CYP3A4—Prednisolone—psoriasis	0.00331	0.00494	CbGbCtD
Paclitaxel—ABCB1—Dexamethasone—psoriasis	0.00326	0.00486	CbGbCtD
Paclitaxel—CYP3A4—Hydrocortisone—psoriasis	0.00314	0.00468	CbGbCtD
Paclitaxel—CYP3A4—Prednisone—psoriasis	0.00313	0.00466	CbGbCtD
Paclitaxel—CYP3A4—Cyclosporine—psoriasis	0.00296	0.00442	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—psoriasis	0.00262	0.00391	CbGbCtD
Paclitaxel—CYP3A4—Dexamethasone—psoriasis	0.00195	0.00291	CbGbCtD
Paclitaxel—BCL2—Isotretinoin—Acitretin—psoriasis	0.00103	0.217	CbGdCrCtD
Paclitaxel—BCL2—Tretinoin—Acitretin—psoriasis	0.00103	0.217	CbGdCrCtD
Paclitaxel—BCL2—Alitretinoin—Acitretin—psoriasis	0.00103	0.217	CbGdCrCtD
Paclitaxel—TUBB6—Vitamin A—Acitretin—psoriasis	0.000536	0.113	CbGdCrCtD
Paclitaxel—TUBB4B—skin epidermis—psoriasis	0.000439	0.127	CbGeAlD
Paclitaxel—TUBB6—Tretinoin—Acitretin—psoriasis	0.000375	0.0787	CbGdCrCtD
Paclitaxel—TUBB6—Isotretinoin—Acitretin—psoriasis	0.000375	0.0787	CbGdCrCtD
Paclitaxel—TUBB6—Alitretinoin—Acitretin—psoriasis	0.000375	0.0787	CbGdCrCtD
Paclitaxel—MAP4—skin of body—psoriasis	0.000287	0.0829	CbGeAlD
Paclitaxel—MAPT—tendon—psoriasis	0.000277	0.0803	CbGeAlD
Paclitaxel—BCL2—skin of body—psoriasis	0.000261	0.0753	CbGeAlD
Paclitaxel—MAP4—tendon—psoriasis	0.000218	0.0631	CbGeAlD
Paclitaxel—TUBB4A—skin of body—psoriasis	0.000174	0.0504	CbGeAlD
Paclitaxel—MAP2—tendon—psoriasis	0.000172	0.0497	CbGeAlD
Paclitaxel—TUBB2A—skin of body—psoriasis	0.000159	0.0459	CbGeAlD
Paclitaxel—TUBB6—skin of body—psoriasis	0.000156	0.0453	CbGeAlD
Paclitaxel—TUBB4B—skin of body—psoriasis	0.000136	0.0393	CbGeAlD
Paclitaxel—TUBB4A—tendon—psoriasis	0.000133	0.0384	CbGeAlD
Paclitaxel—TUBB2B—tendon—psoriasis	0.000128	0.0371	CbGeAlD
Paclitaxel—TUBB—tendon—psoriasis	0.000121	0.0351	CbGeAlD
Paclitaxel—TUBB2A—tendon—psoriasis	0.000121	0.0349	CbGeAlD
Paclitaxel—TUBB6—tendon—psoriasis	0.000119	0.0345	CbGeAlD
Paclitaxel—CYP1B1—skin of body—psoriasis	0.000108	0.0312	CbGeAlD
Paclitaxel—ABCC10—tendon—psoriasis	0.000104	0.0302	CbGeAlD
Paclitaxel—TUBB4B—tendon—psoriasis	0.000104	0.0299	CbGeAlD
Paclitaxel—ABCC2—tendon—psoriasis	8.37e-05	0.0242	CbGeAlD
Paclitaxel—CYP1B1—tendon—psoriasis	8.2e-05	0.0237	CbGeAlD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—CP—psoriasis	7.57e-05	0.0011	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	7.54e-05	0.00109	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—NFKB1—psoriasis	7.54e-05	0.00109	CbGpPWpGaD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	7.42e-05	0.00107	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—REN—psoriasis	7.4e-05	0.00107	CbGpPWpGaD
Paclitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.4e-05	0.00107	CbGpPWpGaD
Paclitaxel—ABCC1—tendon—psoriasis	7.38e-05	0.0213	CbGeAlD
Paclitaxel—BCL2—Apoptosis—TNF—psoriasis	7.22e-05	0.00105	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—CARM1—psoriasis	7.22e-05	0.00105	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TNF—psoriasis	7.2e-05	0.00104	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.1e-05	0.00103	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.09e-05	0.00103	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.09e-05	0.00103	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.93e-05	0.001	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—CP—psoriasis	6.92e-05	0.001	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IFIH1—psoriasis	6.89e-05	0.000998	CbGpPWpGaD
Paclitaxel—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.84e-05	0.00099	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TNF—psoriasis	6.75e-05	0.000977	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—NDUFA5—psoriasis	6.73e-05	0.000974	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERAP1—psoriasis	6.63e-05	0.000959	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—CARM1—psoriasis	6.6e-05	0.000956	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.57e-05	0.000951	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HLA-C—psoriasis	6.53e-05	0.000946	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	6.46e-05	0.000935	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—TNFAIP3—psoriasis	6.45e-05	0.000934	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—CARM1—psoriasis	6.44e-05	0.000932	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—JUN—psoriasis	6.41e-05	0.000928	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—psoriasis	6.37e-05	0.000922	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TP53—psoriasis	6.34e-05	0.000918	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—NDUFA5—psoriasis	6.33e-05	0.000917	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.27e-05	0.000908	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	6.25e-05	0.000905	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—ACE—psoriasis	6.15e-05	0.00089	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—ACE—psoriasis	6.15e-05	0.00089	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.09e-05	0.000881	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—JUN—psoriasis	6.03e-05	0.000874	CbGpPWpGaD
Paclitaxel—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.98e-05	0.000866	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TP53—psoriasis	5.97e-05	0.000865	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	5.97e-05	0.000864	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL10—psoriasis	5.95e-05	0.000861	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TP53—psoriasis	5.95e-05	0.000861	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—ACE—psoriasis	5.94e-05	0.000859	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.91e-05	0.000855	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—DDX58—psoriasis	5.83e-05	0.000844	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—NFKB1—psoriasis	5.81e-05	0.000841	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—IL4—psoriasis	5.79e-05	0.000838	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—ACE—psoriasis	5.75e-05	0.000832	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CYP2S1—psoriasis	5.72e-05	0.000828	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.66e-05	0.000819	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.65e-05	0.000818	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.64e-05	0.000817	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—PCNA—psoriasis	5.63e-05	0.000815	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—ACE—psoriasis	5.62e-05	0.000814	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—PPARG—psoriasis	5.57e-05	0.000806	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HLA-E—psoriasis	5.42e-05	0.000785	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CYP2S1—psoriasis	5.39e-05	0.000779	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.37e-05	0.000777	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TP53—psoriasis	5.33e-05	0.000771	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—VEGFA—psoriasis	5.27e-05	0.000763	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.27e-05	0.000762	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.24e-05	0.000759	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—psoriasis	5.17e-05	0.000748	CbGpPWpGaD
Paclitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.16e-05	0.000746	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—ACE—psoriasis	5.05e-05	0.000731	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—PCNA—psoriasis	5.04e-05	0.000729	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—JUN—psoriasis	5.02e-05	0.000727	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5e-05	0.000724	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—IL6—psoriasis	4.88e-05	0.000706	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	4.81e-05	0.000697	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.79e-05	0.000693	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NDUFA5—psoriasis	4.78e-05	0.000692	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NDUFA5—psoriasis	4.76e-05	0.000689	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—PCNA—psoriasis	4.67e-05	0.000675	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—ACE—psoriasis	4.62e-05	0.000668	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NDUFA5—psoriasis	4.6e-05	0.000666	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—SOCS1—psoriasis	4.53e-05	0.000656	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	4.47e-05	0.000648	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.46e-05	0.000645	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.44e-05	0.000642	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TNF—psoriasis	4.43e-05	0.000641	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	4.42e-05	0.00064	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ITGAL—psoriasis	4.42e-05	0.00064	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—VEGFA—psoriasis	4.39e-05	0.000635	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.37e-05	0.000632	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.29e-05	0.000621	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	4.27e-05	0.000618	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—PCNA—psoriasis	4.27e-05	0.000618	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—psoriasis	4.23e-05	0.000613	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	4.22e-05	0.000611	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NDUFA5—psoriasis	4.19e-05	0.000606	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—PCNA—psoriasis	4.17e-05	0.000604	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NDUFA5—psoriasis	4.15e-05	0.000601	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—REL—psoriasis	4.14e-05	0.000599	CbGpPWpGaD
Paclitaxel—Dermatitis—Mycophenolic acid—psoriasis	4.13e-05	0.000164	CcSEcCtD
Paclitaxel—Pain—Prednisolone—psoriasis	4.13e-05	0.000163	CcSEcCtD
Paclitaxel—Haemorrhage—Methotrexate—psoriasis	4.13e-05	0.000163	CcSEcCtD
Paclitaxel—Urticaria—Mycophenolate mofetil—psoriasis	4.11e-05	0.000163	CcSEcCtD
Paclitaxel—Headache—Mycophenolic acid—psoriasis	4.11e-05	0.000163	CcSEcCtD
Paclitaxel—Decreased appetite—Hydrocortisone—psoriasis	4.1e-05	0.000162	CcSEcCtD
Paclitaxel—Pharyngitis—Methotrexate—psoriasis	4.1e-05	0.000162	CcSEcCtD
Paclitaxel—Body temperature increased—Mycophenolate mofetil—psoriasis	4.09e-05	0.000162	CcSEcCtD
Paclitaxel—Abdominal pain—Mycophenolate mofetil—psoriasis	4.09e-05	0.000162	CcSEcCtD
Paclitaxel—Urinary tract disorder—Methotrexate—psoriasis	4.07e-05	0.000161	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.07e-05	0.000161	CcSEcCtD
Paclitaxel—Fatigue—Hydrocortisone—psoriasis	4.06e-05	0.000161	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism—CYP2S1—psoriasis	4.06e-05	0.000588	CbGpPWpGaD
Paclitaxel—Vision blurred—Prednisone—psoriasis	4.05e-05	0.00016	CcSEcCtD
Paclitaxel—ABCC1—Metabolism—CYP2S1—psoriasis	4.05e-05	0.000586	CbGpPWpGaD
Paclitaxel—Urethral disorder—Methotrexate—psoriasis	4.04e-05	0.00016	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.04e-05	0.00016	CcSEcCtD
Paclitaxel—Pain—Hydrocortisone—psoriasis	4.03e-05	0.00016	CcSEcCtD
Paclitaxel—Anaphylactic shock—Dexamethasone—psoriasis	4.03e-05	0.000159	CcSEcCtD
Paclitaxel—Oedema—Betamethasone—psoriasis	4.03e-05	0.000159	CcSEcCtD
Paclitaxel—Anaphylactic shock—Betamethasone—psoriasis	4.03e-05	0.000159	CcSEcCtD
Paclitaxel—Oedema—Dexamethasone—psoriasis	4.03e-05	0.000159	CcSEcCtD
Paclitaxel—Insomnia—Triamcinolone—psoriasis	4.01e-05	0.000159	CcSEcCtD
Paclitaxel—BCL2—Immune System—IFIH1—psoriasis	4.01e-05	0.000581	CbGpPWpGaD
Paclitaxel—Infection—Betamethasone—psoriasis	4e-05	0.000158	CcSEcCtD
Paclitaxel—Infection—Dexamethasone—psoriasis	4e-05	0.000158	CcSEcCtD
Paclitaxel—Ill-defined disorder—Prednisone—psoriasis	3.99e-05	0.000158	CcSEcCtD
Paclitaxel—Paraesthesia—Triamcinolone—psoriasis	3.99e-05	0.000158	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—psoriasis	3.98e-05	0.000577	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Prednisolone—psoriasis	3.98e-05	0.000157	CcSEcCtD
Paclitaxel—Visual impairment—Methotrexate—psoriasis	3.98e-05	0.000157	CcSEcCtD
Paclitaxel—Anaemia—Prednisone—psoriasis	3.97e-05	0.000157	CcSEcCtD
Paclitaxel—Shock—Dexamethasone—psoriasis	3.96e-05	0.000157	CcSEcCtD
Paclitaxel—Shock—Betamethasone—psoriasis	3.96e-05	0.000157	CcSEcCtD
Paclitaxel—Dyspnoea—Triamcinolone—psoriasis	3.96e-05	0.000157	CcSEcCtD
Paclitaxel—Nervous system disorder—Betamethasone—psoriasis	3.95e-05	0.000156	CcSEcCtD
Paclitaxel—Nervous system disorder—Dexamethasone—psoriasis	3.95e-05	0.000156	CcSEcCtD
Paclitaxel—Agitation—Prednisone—psoriasis	3.95e-05	0.000156	CcSEcCtD
Paclitaxel—Thrombocytopenia—Betamethasone—psoriasis	3.94e-05	0.000156	CcSEcCtD
Paclitaxel—Thrombocytopenia—Dexamethasone—psoriasis	3.94e-05	0.000156	CcSEcCtD
Paclitaxel—Tachycardia—Dexamethasone—psoriasis	3.93e-05	0.000156	CcSEcCtD
Paclitaxel—Tachycardia—Betamethasone—psoriasis	3.93e-05	0.000156	CcSEcCtD
Paclitaxel—Angioedema—Prednisone—psoriasis	3.93e-05	0.000155	CcSEcCtD
Paclitaxel—CYP1B1—Metabolism—CYP2S1—psoriasis	3.91e-05	0.000566	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Cyclosporine—psoriasis	3.91e-05	0.000155	CcSEcCtD
Paclitaxel—Dyspepsia—Triamcinolone—psoriasis	3.91e-05	0.000155	CcSEcCtD
Paclitaxel—BCL2—Apoptosis—TP53—psoriasis	3.9e-05	0.000565	CbGpPWpGaD
Paclitaxel—Erythema multiforme—Methotrexate—psoriasis	3.9e-05	0.000154	CcSEcCtD
Paclitaxel—Nausea—Mycophenolic acid—psoriasis	3.89e-05	0.000154	CcSEcCtD
Paclitaxel—Hyperhidrosis—Dexamethasone—psoriasis	3.89e-05	0.000154	CcSEcCtD
Paclitaxel—Hyperhidrosis—Betamethasone—psoriasis	3.89e-05	0.000154	CcSEcCtD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	3.89e-05	0.000563	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Hydrocortisone—psoriasis	3.88e-05	0.000154	CcSEcCtD
Paclitaxel—Malaise—Prednisone—psoriasis	3.88e-05	0.000153	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—HLA-B—psoriasis	3.86e-05	0.000559	CbGpPWpGaD
Paclitaxel—Vertigo—Prednisone—psoriasis	3.86e-05	0.000153	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—psoriasis	3.86e-05	0.000153	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Hydrocortisone—psoriasis	3.85e-05	0.000153	CcSEcCtD
Paclitaxel—Syncope—Prednisone—psoriasis	3.85e-05	0.000153	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—psoriasis	3.85e-05	0.000152	CcSEcCtD
Paclitaxel—NR1I2—Gene Expression—VDR—psoriasis	3.84e-05	0.000556	CbGpPWpGaD
Paclitaxel—Anorexia—Dexamethasone—psoriasis	3.84e-05	0.000152	CcSEcCtD
Paclitaxel—Anorexia—Betamethasone—psoriasis	3.84e-05	0.000152	CcSEcCtD
Paclitaxel—Urticaria—Prednisolone—psoriasis	3.83e-05	0.000152	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—psoriasis	3.83e-05	0.000152	CcSEcCtD
Paclitaxel—Fatigue—Triamcinolone—psoriasis	3.83e-05	0.000152	CcSEcCtD
Paclitaxel—TUBB2B—Metabolism of proteins—LEP—psoriasis	3.82e-05	0.000553	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—LEP—psoriasis	3.82e-05	0.000553	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—PCNA—psoriasis	3.82e-05	0.000552	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.81e-05	0.000151	CcSEcCtD
Paclitaxel—BCL2—Immune System—HLA-C—psoriasis	3.81e-05	0.000551	CbGpPWpGaD
Paclitaxel—Asthenia—Cyclosporine—psoriasis	3.81e-05	0.000151	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	3.8e-05	0.00055	CbGpPWpGaD
Paclitaxel—Pain—Triamcinolone—psoriasis	3.8e-05	0.00015	CcSEcCtD
Paclitaxel—Loss of consciousness—Prednisone—psoriasis	3.78e-05	0.00015	CcSEcCtD
Paclitaxel—Hypotension—Dexamethasone—psoriasis	3.76e-05	0.000149	CcSEcCtD
Paclitaxel—Hypotension—Betamethasone—psoriasis	3.76e-05	0.000149	CcSEcCtD
Paclitaxel—BCL2—Immune System—TNFAIP3—psoriasis	3.76e-05	0.000544	CbGpPWpGaD
Paclitaxel—Pruritus—Cyclosporine—psoriasis	3.75e-05	0.000149	CcSEcCtD
Paclitaxel—Urticaria—Hydrocortisone—psoriasis	3.75e-05	0.000148	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.74e-05	0.000542	CbGpPWpGaD
Paclitaxel—Angiopathy—Methotrexate—psoriasis	3.74e-05	0.000148	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—psoriasis	3.73e-05	0.000148	CcSEcCtD
Paclitaxel—Body temperature increased—Hydrocortisone—psoriasis	3.73e-05	0.000148	CcSEcCtD
Paclitaxel—Abdominal pain—Hydrocortisone—psoriasis	3.73e-05	0.000148	CcSEcCtD
Paclitaxel—Convulsion—Prednisone—psoriasis	3.72e-05	0.000147	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—psoriasis	3.72e-05	0.000147	CcSEcCtD
Paclitaxel—Asthenia—Mycophenolate mofetil—psoriasis	3.71e-05	0.000147	CcSEcCtD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.71e-05	0.000537	CbGpPWpGaD
Paclitaxel—Hypertension—Prednisone—psoriasis	3.71e-05	0.000147	CcSEcCtD
Paclitaxel—Chills—Methotrexate—psoriasis	3.7e-05	0.000147	CcSEcCtD
Paclitaxel—TUBB3—Metabolism of proteins—LEP—psoriasis	3.69e-05	0.000534	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Betamethasone—psoriasis	3.67e-05	0.000145	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.67e-05	0.000145	CcSEcCtD
Paclitaxel—Pruritus—Mycophenolate mofetil—psoriasis	3.66e-05	0.000145	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	3.66e-05	0.00053	CbGpPWpGaD
Paclitaxel—Arthralgia—Prednisone—psoriasis	3.66e-05	0.000145	CcSEcCtD
Paclitaxel—Myalgia—Prednisone—psoriasis	3.66e-05	0.000145	CcSEcCtD
Paclitaxel—Feeling abnormal—Triamcinolone—psoriasis	3.66e-05	0.000145	CcSEcCtD
Paclitaxel—Anxiety—Prednisone—psoriasis	3.65e-05	0.000144	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—psoriasis	3.65e-05	0.000144	CcSEcCtD
Paclitaxel—Insomnia—Betamethasone—psoriasis	3.64e-05	0.000144	CcSEcCtD
Paclitaxel—Insomnia—Dexamethasone—psoriasis	3.64e-05	0.000144	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.63e-05	0.000144	CcSEcCtD
Paclitaxel—Diarrhoea—Cyclosporine—psoriasis	3.63e-05	0.000144	CcSEcCtD
Paclitaxel—Paraesthesia—Dexamethasone—psoriasis	3.62e-05	0.000143	CcSEcCtD
Paclitaxel—Paraesthesia—Betamethasone—psoriasis	3.62e-05	0.000143	CcSEcCtD
Paclitaxel—Discomfort—Prednisone—psoriasis	3.62e-05	0.000143	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—psoriasis	3.61e-05	0.000143	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—psoriasis	3.59e-05	0.000142	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—psoriasis	3.59e-05	0.000142	CcSEcCtD
Paclitaxel—TUBB2A—Metabolism of proteins—LEP—psoriasis	3.57e-05	0.000517	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP2S1—psoriasis	3.56e-05	0.000515	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Prednisolone—psoriasis	3.56e-05	0.000141	CcSEcCtD
Paclitaxel—Dyspepsia—Dexamethasone—psoriasis	3.55e-05	0.00014	CcSEcCtD
Paclitaxel—Dyspepsia—Betamethasone—psoriasis	3.55e-05	0.00014	CcSEcCtD
Paclitaxel—Diarrhoea—Mycophenolate mofetil—psoriasis	3.54e-05	0.00014	CcSEcCtD
Paclitaxel—CYP3A7—Metabolism—CYP2S1—psoriasis	3.53e-05	0.000511	CbGpPWpGaD
Paclitaxel—Urticaria—Triamcinolone—psoriasis	3.53e-05	0.00014	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—psoriasis	3.52e-05	0.000139	CcSEcCtD
Paclitaxel—Body temperature increased—Triamcinolone—psoriasis	3.51e-05	0.000139	CcSEcCtD
Paclitaxel—Dizziness—Cyclosporine—psoriasis	3.51e-05	0.000139	CcSEcCtD
Paclitaxel—Oedema—Prednisone—psoriasis	3.51e-05	0.000139	CcSEcCtD
Paclitaxel—Anaphylactic shock—Prednisone—psoriasis	3.51e-05	0.000139	CcSEcCtD
Paclitaxel—Decreased appetite—Betamethasone—psoriasis	3.5e-05	0.000139	CcSEcCtD
Paclitaxel—Decreased appetite—Dexamethasone—psoriasis	3.5e-05	0.000139	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—IFNG—psoriasis	3.5e-05	0.000506	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—LEP—psoriasis	3.49e-05	0.000506	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.49e-05	0.000505	CbGpPWpGaD
Paclitaxel—Infection—Prednisone—psoriasis	3.48e-05	0.000138	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Betamethasone—psoriasis	3.48e-05	0.000138	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Dexamethasone—psoriasis	3.48e-05	0.000138	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—psoriasis	3.47e-05	0.000138	CcSEcCtD
Paclitaxel—Hypersensitivity—Hydrocortisone—psoriasis	3.47e-05	0.000138	CcSEcCtD
Paclitaxel—Fatigue—Betamethasone—psoriasis	3.47e-05	0.000137	CcSEcCtD
Paclitaxel—Fatigue—Dexamethasone—psoriasis	3.47e-05	0.000137	CcSEcCtD
Paclitaxel—Shock—Prednisone—psoriasis	3.45e-05	0.000137	CcSEcCtD
Paclitaxel—Pain—Dexamethasone—psoriasis	3.44e-05	0.000136	CcSEcCtD
Paclitaxel—Pain—Betamethasone—psoriasis	3.44e-05	0.000136	CcSEcCtD
Paclitaxel—Nervous system disorder—Prednisone—psoriasis	3.44e-05	0.000136	CcSEcCtD
Paclitaxel—Tachycardia—Prednisone—psoriasis	3.42e-05	0.000136	CcSEcCtD
Paclitaxel—Dizziness—Mycophenolate mofetil—psoriasis	3.42e-05	0.000135	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—CRP—psoriasis	3.42e-05	0.000494	CbGpPWpGaD
Paclitaxel—Skin disorder—Prednisone—psoriasis	3.41e-05	0.000135	CcSEcCtD
Paclitaxel—Hyperhidrosis—Prednisone—psoriasis	3.39e-05	0.000134	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—psoriasis	3.38e-05	0.000134	CcSEcCtD
Paclitaxel—Asthenia—Hydrocortisone—psoriasis	3.38e-05	0.000134	CcSEcCtD
Paclitaxel—Vomiting—Cyclosporine—psoriasis	3.37e-05	0.000134	CcSEcCtD
Paclitaxel—Rash—Cyclosporine—psoriasis	3.34e-05	0.000132	CcSEcCtD
Paclitaxel—Anorexia—Prednisone—psoriasis	3.34e-05	0.000132	CcSEcCtD
Paclitaxel—Dermatitis—Cyclosporine—psoriasis	3.34e-05	0.000132	CcSEcCtD
Paclitaxel—Pruritus—Hydrocortisone—psoriasis	3.34e-05	0.000132	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—psoriasis	3.33e-05	0.000132	CcSEcCtD
Paclitaxel—Headache—Cyclosporine—psoriasis	3.32e-05	0.000132	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	3.32e-05	0.000481	CbGpPWpGaD
Paclitaxel—Anaemia—Methotrexate—psoriasis	3.32e-05	0.000131	CcSEcCtD
Paclitaxel—Feeling abnormal—Betamethasone—psoriasis	3.32e-05	0.000131	CcSEcCtD
Paclitaxel—Feeling abnormal—Dexamethasone—psoriasis	3.32e-05	0.000131	CcSEcCtD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.3e-05	0.000478	CbGpPWpGaD
Paclitaxel—Gastrointestinal pain—Betamethasone—psoriasis	3.29e-05	0.00013	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Dexamethasone—psoriasis	3.29e-05	0.00013	CcSEcCtD
Paclitaxel—Vomiting—Mycophenolate mofetil—psoriasis	3.29e-05	0.00013	CcSEcCtD
Paclitaxel—Hypersensitivity—Triamcinolone—psoriasis	3.27e-05	0.000129	CcSEcCtD
Paclitaxel—Rash—Mycophenolate mofetil—psoriasis	3.26e-05	0.000129	CcSEcCtD
Paclitaxel—Dermatitis—Mycophenolate mofetil—psoriasis	3.26e-05	0.000129	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.25e-05	0.000471	CbGpPWpGaD
Paclitaxel—Headache—Mycophenolate mofetil—psoriasis	3.24e-05	0.000128	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—psoriasis	3.24e-05	0.000128	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—psoriasis	3.23e-05	0.000128	CcSEcCtD
Paclitaxel—Diarrhoea—Hydrocortisone—psoriasis	3.23e-05	0.000128	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—psoriasis	3.22e-05	0.000127	CcSEcCtD
Paclitaxel—Urticaria—Dexamethasone—psoriasis	3.2e-05	0.000127	CcSEcCtD
Paclitaxel—Urticaria—Betamethasone—psoriasis	3.2e-05	0.000127	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Prednisone—psoriasis	3.2e-05	0.000127	CcSEcCtD
Paclitaxel—Dizziness—Prednisolone—psoriasis	3.19e-05	0.000126	CcSEcCtD
Paclitaxel—Asthenia—Triamcinolone—psoriasis	3.18e-05	0.000126	CcSEcCtD
Paclitaxel—Abdominal pain—Dexamethasone—psoriasis	3.18e-05	0.000126	CcSEcCtD
Paclitaxel—Body temperature increased—Betamethasone—psoriasis	3.18e-05	0.000126	CcSEcCtD
Paclitaxel—Abdominal pain—Betamethasone—psoriasis	3.18e-05	0.000126	CcSEcCtD
Paclitaxel—Body temperature increased—Dexamethasone—psoriasis	3.18e-05	0.000126	CcSEcCtD
Paclitaxel—Insomnia—Prednisone—psoriasis	3.17e-05	0.000126	CcSEcCtD
Paclitaxel—BCL2—Immune System—HLA-E—psoriasis	3.16e-05	0.000457	CbGpPWpGaD
Paclitaxel—Nausea—Cyclosporine—psoriasis	3.15e-05	0.000125	CcSEcCtD
Paclitaxel—Paraesthesia—Prednisone—psoriasis	3.15e-05	0.000125	CcSEcCtD
Paclitaxel—Pruritus—Triamcinolone—psoriasis	3.14e-05	0.000124	CcSEcCtD
Paclitaxel—TUBB4A—Metabolism of proteins—LEP—psoriasis	3.14e-05	0.000454	CbGpPWpGaD
Paclitaxel—Cough—Methotrexate—psoriasis	3.13e-05	0.000124	CcSEcCtD
Paclitaxel—Dizziness—Hydrocortisone—psoriasis	3.12e-05	0.000123	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—NFKBIA—psoriasis	3.11e-05	0.000451	CbGpPWpGaD
Paclitaxel—Convulsion—Methotrexate—psoriasis	3.11e-05	0.000123	CcSEcCtD
Paclitaxel—Dyspepsia—Prednisone—psoriasis	3.09e-05	0.000122	CcSEcCtD
Paclitaxel—Nausea—Mycophenolate mofetil—psoriasis	3.07e-05	0.000122	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—psoriasis	3.06e-05	0.000121	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—psoriasis	3.06e-05	0.000121	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—psoriasis	3.06e-05	0.000121	CcSEcCtD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.05e-05	0.000442	CbGpPWpGaD
Paclitaxel—Decreased appetite—Prednisone—psoriasis	3.05e-05	0.000121	CcSEcCtD
Paclitaxel—Rash—Prednisolone—psoriasis	3.04e-05	0.000121	CcSEcCtD
Paclitaxel—Dermatitis—Prednisolone—psoriasis	3.04e-05	0.00012	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.04e-05	0.00012	CcSEcCtD
Paclitaxel—Fatigue—Prednisone—psoriasis	3.02e-05	0.00012	CcSEcCtD
Paclitaxel—Headache—Prednisolone—psoriasis	3.02e-05	0.00012	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—psoriasis	3.02e-05	0.00012	CcSEcCtD
Paclitaxel—CYP3A5—Metabolism—NDUFA5—psoriasis	3e-05	0.000434	CbGpPWpGaD
Paclitaxel—Constipation—Prednisone—psoriasis	3e-05	0.000119	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3e-05	0.000434	CbGpPWpGaD
Paclitaxel—Vomiting—Hydrocortisone—psoriasis	3e-05	0.000119	CcSEcCtD
Paclitaxel—Rash—Hydrocortisone—psoriasis	2.97e-05	0.000118	CcSEcCtD
Paclitaxel—Dermatitis—Hydrocortisone—psoriasis	2.97e-05	0.000118	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—psoriasis	2.96e-05	0.000117	CcSEcCtD
Paclitaxel—Headache—Hydrocortisone—psoriasis	2.95e-05	0.000117	CcSEcCtD
Paclitaxel—Dizziness—Triamcinolone—psoriasis	2.94e-05	0.000116	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—psoriasis	2.93e-05	0.000116	CcSEcCtD
Paclitaxel—Infection—Methotrexate—psoriasis	2.91e-05	0.000115	CcSEcCtD
Paclitaxel—Feeling abnormal—Prednisone—psoriasis	2.89e-05	0.000114	CcSEcCtD
Paclitaxel—Asthenia—Betamethasone—psoriasis	2.89e-05	0.000114	CcSEcCtD
Paclitaxel—Asthenia—Dexamethasone—psoriasis	2.89e-05	0.000114	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—psoriasis	2.87e-05	0.000114	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—psoriasis	2.87e-05	0.000114	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Prednisone—psoriasis	2.87e-05	0.000114	CcSEcCtD
Paclitaxel—TUBB4B—Metabolism of proteins—LEP—psoriasis	2.87e-05	0.000415	CbGpPWpGaD
Paclitaxel—Nausea—Prednisolone—psoriasis	2.87e-05	0.000114	CcSEcCtD
Paclitaxel—Pruritus—Betamethasone—psoriasis	2.85e-05	0.000113	CcSEcCtD
Paclitaxel—Pruritus—Dexamethasone—psoriasis	2.85e-05	0.000113	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—psoriasis	2.85e-05	0.000113	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—psoriasis	2.83e-05	0.000112	CcSEcCtD
Paclitaxel—Vomiting—Triamcinolone—psoriasis	2.82e-05	0.000112	CcSEcCtD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.82e-05	0.000409	CbGpPWpGaD
Paclitaxel—Nausea—Hydrocortisone—psoriasis	2.8e-05	0.000111	CcSEcCtD
Paclitaxel—Rash—Triamcinolone—psoriasis	2.8e-05	0.000111	CcSEcCtD
Paclitaxel—Dermatitis—Triamcinolone—psoriasis	2.8e-05	0.000111	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism—CARM1—psoriasis	2.79e-05	0.000404	CbGpPWpGaD
Paclitaxel—Anorexia—Methotrexate—psoriasis	2.79e-05	0.000111	CcSEcCtD
Paclitaxel—Urticaria—Prednisone—psoriasis	2.79e-05	0.00011	CcSEcCtD
Paclitaxel—Headache—Triamcinolone—psoriasis	2.78e-05	0.00011	CcSEcCtD
Paclitaxel—Abdominal pain—Prednisone—psoriasis	2.77e-05	0.00011	CcSEcCtD
Paclitaxel—Body temperature increased—Prednisone—psoriasis	2.77e-05	0.00011	CcSEcCtD
Paclitaxel—Diarrhoea—Dexamethasone—psoriasis	2.76e-05	0.000109	CcSEcCtD
Paclitaxel—Diarrhoea—Betamethasone—psoriasis	2.76e-05	0.000109	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—psoriasis	2.74e-05	0.000108	CcSEcCtD
Paclitaxel—NR1I2—Gene Expression—PPARG—psoriasis	2.68e-05	0.000388	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.68e-05	0.000388	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—psoriasis	2.67e-05	0.000106	CcSEcCtD
Paclitaxel—Dizziness—Dexamethasone—psoriasis	2.66e-05	0.000105	CcSEcCtD
Paclitaxel—Dizziness—Betamethasone—psoriasis	2.66e-05	0.000105	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—psoriasis	2.65e-05	0.000105	CcSEcCtD
Paclitaxel—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.64e-05	0.000382	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—SOCS1—psoriasis	2.64e-05	0.000382	CbGpPWpGaD
Paclitaxel—Nausea—Triamcinolone—psoriasis	2.64e-05	0.000104	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—psoriasis	2.63e-05	0.000104	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—CARM1—psoriasis	2.63e-05	0.000381	CbGpPWpGaD
Paclitaxel—Dyspnoea—Methotrexate—psoriasis	2.61e-05	0.000103	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.61e-05	0.000378	CbGpPWpGaD
Paclitaxel—Somnolence—Methotrexate—psoriasis	2.61e-05	0.000103	CcSEcCtD
Paclitaxel—CYP2C8—Metabolism—NDUFA5—psoriasis	2.6e-05	0.000376	CbGpPWpGaD
Paclitaxel—Hypersensitivity—Prednisone—psoriasis	2.58e-05	0.000102	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—psoriasis	2.58e-05	0.000102	CcSEcCtD
Paclitaxel—Vomiting—Dexamethasone—psoriasis	2.56e-05	0.000101	CcSEcCtD
Paclitaxel—Vomiting—Betamethasone—psoriasis	2.56e-05	0.000101	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—TYK2—psoriasis	2.55e-05	0.000369	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP2S1—psoriasis	2.55e-05	0.000369	CbGpPWpGaD
Paclitaxel—Decreased appetite—Methotrexate—psoriasis	2.55e-05	0.000101	CcSEcCtD
Paclitaxel—Rash—Betamethasone—psoriasis	2.54e-05	0.000101	CcSEcCtD
Paclitaxel—Rash—Dexamethasone—psoriasis	2.54e-05	0.000101	CcSEcCtD
Paclitaxel—TUBB6—Metabolism of proteins—CXCL8—psoriasis	2.54e-05	0.000367	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—CXCL8—psoriasis	2.54e-05	0.000367	CbGpPWpGaD
Paclitaxel—Dermatitis—Dexamethasone—psoriasis	2.54e-05	0.0001	CcSEcCtD
Paclitaxel—Dermatitis—Betamethasone—psoriasis	2.54e-05	0.0001	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—psoriasis	2.53e-05	0.0001	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—psoriasis	2.53e-05	0.0001	CcSEcCtD
Paclitaxel—Headache—Betamethasone—psoriasis	2.52e-05	9.99e-05	CcSEcCtD
Paclitaxel—Headache—Dexamethasone—psoriasis	2.52e-05	9.99e-05	CcSEcCtD
Paclitaxel—Asthenia—Prednisone—psoriasis	2.52e-05	9.96e-05	CcSEcCtD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	2.51e-05	0.000363	CbGpPWpGaD
Paclitaxel—Pain—Methotrexate—psoriasis	2.51e-05	9.93e-05	CcSEcCtD
Paclitaxel—Pruritus—Prednisone—psoriasis	2.48e-05	9.83e-05	CcSEcCtD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.46e-05	0.000356	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—CXCL8—psoriasis	2.45e-05	0.000355	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.42e-05	0.000351	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Methotrexate—psoriasis	2.42e-05	9.56e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Prednisone—psoriasis	2.4e-05	9.5e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—psoriasis	2.4e-05	9.49e-05	CcSEcCtD
Paclitaxel—Nausea—Betamethasone—psoriasis	2.39e-05	9.47e-05	CcSEcCtD
Paclitaxel—Nausea—Dexamethasone—psoriasis	2.39e-05	9.47e-05	CcSEcCtD
Paclitaxel—TUBB2A—Metabolism of proteins—CXCL8—psoriasis	2.37e-05	0.000344	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD8A—psoriasis	2.34e-05	0.000339	CbGpPWpGaD
Paclitaxel—Urticaria—Methotrexate—psoriasis	2.33e-05	9.22e-05	CcSEcCtD
Paclitaxel—TUBB1—Metabolism of proteins—CXCL8—psoriasis	2.32e-05	0.000336	CbGpPWpGaD
Paclitaxel—Dizziness—Prednisone—psoriasis	2.32e-05	9.18e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—psoriasis	2.32e-05	9.18e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—psoriasis	2.32e-05	9.18e-05	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—CD4—psoriasis	2.31e-05	0.000334	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TNF—psoriasis	2.26e-05	0.000328	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NDUFA5—psoriasis	2.26e-05	0.000328	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.25e-05	0.000326	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-B—psoriasis	2.25e-05	0.000326	CbGpPWpGaD
Paclitaxel—Vomiting—Prednisone—psoriasis	2.23e-05	8.83e-05	CcSEcCtD
Paclitaxel—Rash—Prednisone—psoriasis	2.21e-05	8.76e-05	CcSEcCtD
Paclitaxel—Dermatitis—Prednisone—psoriasis	2.21e-05	8.75e-05	CcSEcCtD
Paclitaxel—CYP2C8—Metabolism—CYP2S1—psoriasis	2.21e-05	0.00032	CbGpPWpGaD
Paclitaxel—Headache—Prednisone—psoriasis	2.2e-05	8.7e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—psoriasis	2.16e-05	8.55e-05	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.13e-05	0.000308	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.12e-05	0.000307	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NDUFA5—psoriasis	2.11e-05	0.000306	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.1e-05	0.000304	CbGpPWpGaD
Paclitaxel—Asthenia—Methotrexate—psoriasis	2.1e-05	8.33e-05	CcSEcCtD
Paclitaxel—BCL2—Immune System—HLA-A—psoriasis	2.09e-05	0.000302	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CXCL8—psoriasis	2.08e-05	0.000302	CbGpPWpGaD
Paclitaxel—Nausea—Prednisone—psoriasis	2.08e-05	8.25e-05	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—psoriasis	2.07e-05	8.21e-05	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—JUN—psoriasis	2.06e-05	0.000299	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.05e-05	0.000297	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.01e-05	0.00029	CbGpPWpGaD
Paclitaxel—Diarrhoea—Methotrexate—psoriasis	2.01e-05	7.94e-05	CcSEcCtD
Paclitaxel—BCL2—Immune System—CRP—psoriasis	1.99e-05	0.000288	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NFKB1—psoriasis	1.99e-05	0.000288	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CARM1—psoriasis	1.98e-05	0.000287	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CARM1—psoriasis	1.98e-05	0.000286	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.97e-05	0.000285	CbGpPWpGaD
Paclitaxel—Dizziness—Methotrexate—psoriasis	1.94e-05	7.68e-05	CcSEcCtD
Paclitaxel—ABCB1—Metabolism—CYP2S1—psoriasis	1.92e-05	0.000279	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CARM1—psoriasis	1.91e-05	0.000277	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CXCL8—psoriasis	1.91e-05	0.000276	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DRB1—psoriasis	1.91e-05	0.000276	CbGpPWpGaD
Paclitaxel—Vomiting—Methotrexate—psoriasis	1.86e-05	7.38e-05	CcSEcCtD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.85e-05	0.000268	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—psoriasis	1.85e-05	0.000268	CbGpPWpGaD
Paclitaxel—Rash—Methotrexate—psoriasis	1.85e-05	7.32e-05	CcSEcCtD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.85e-05	0.000267	CbGpPWpGaD
Paclitaxel—Dermatitis—Methotrexate—psoriasis	1.85e-05	7.31e-05	CcSEcCtD
Paclitaxel—Headache—Methotrexate—psoriasis	1.84e-05	7.27e-05	CcSEcCtD
Paclitaxel—BCL2—Immune System—ICAM1—psoriasis	1.83e-05	0.000265	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NFKBIA—psoriasis	1.81e-05	0.000263	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2S1—psoriasis	1.8e-05	0.00026	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.79e-05	0.000259	CbGpPWpGaD
Paclitaxel—Nausea—Methotrexate—psoriasis	1.74e-05	6.89e-05	CcSEcCtD
Paclitaxel—ABCG2—Metabolism—CARM1—psoriasis	1.74e-05	0.000252	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CARM1—psoriasis	1.72e-05	0.000249	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CAT—psoriasis	1.72e-05	0.000249	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CAT—psoriasis	1.62e-05	0.000234	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—psoriasis	1.53e-05	0.000222	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.49e-05	0.000216	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—TYK2—psoriasis	1.49e-05	0.000215	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.44e-05	0.000208	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—psoriasis	1.4e-05	0.000203	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NDUFA5—psoriasis	1.39e-05	0.000202	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IFNG—psoriasis	1.39e-05	0.000201	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD4—psoriasis	1.34e-05	0.000195	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—APOE—psoriasis	1.34e-05	0.000193	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.3e-05	0.000189	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—APOE—psoriasis	1.26e-05	0.000182	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—psoriasis	1.25e-05	0.000181	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CARM1—psoriasis	1.25e-05	0.00018	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CAT—psoriasis	1.22e-05	0.000177	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CAT—psoriasis	1.22e-05	0.000176	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HLA-A—psoriasis	1.21e-05	0.000175	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—JUN—psoriasis	1.2e-05	0.000174	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2S1—psoriasis	1.19e-05	0.000172	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CAT—psoriasis	1.18e-05	0.00017	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PPARG—psoriasis	1.16e-05	0.000168	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NFKB1—psoriasis	1.16e-05	0.000168	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000168	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APOE—psoriasis	1.13e-05	0.000163	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.12e-05	0.000162	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PPARG—psoriasis	1.09e-05	0.000158	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CARM1—psoriasis	1.08e-05	0.000156	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CAT—psoriasis	1.07e-05	0.000155	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CAT—psoriasis	1.06e-05	0.000153	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOS2—psoriasis	1.05e-05	0.000152	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—STAT3—psoriasis	1.04e-05	0.000151	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000146	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.85e-06	0.000143	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—APOE—psoriasis	9.48e-06	0.000137	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—APOE—psoriasis	9.44e-06	0.000137	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.42e-06	0.000136	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CARM1—psoriasis	9.4e-06	0.000136	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—APOE—psoriasis	9.13e-06	0.000132	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CARM1—psoriasis	8.78e-06	0.000127	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TYK2—psoriasis	8.6e-06	0.000125	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—APOE—psoriasis	8.31e-06	0.00012	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—psoriasis	8.26e-06	0.00012	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—APOE—psoriasis	8.23e-06	0.000119	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—psoriasis	8.22e-06	0.000119	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.21e-06	0.000119	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—psoriasis	7.95e-06	0.000115	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—psoriasis	7.78e-06	0.000113	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CAT—psoriasis	7.66e-06	0.000111	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—psoriasis	7.27e-06	0.000105	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—psoriasis	7.24e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—psoriasis	7.17e-06	0.000104	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CAT—psoriasis	6.64e-06	9.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—psoriasis	6.03e-06	8.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—APOE—psoriasis	5.95e-06	8.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CARM1—psoriasis	5.79e-06	8.38e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CAT—psoriasis	5.78e-06	8.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CAT—psoriasis	5.4e-06	7.82e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—psoriasis	5.18e-06	7.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—APOE—psoriasis	5.16e-06	7.46e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOE—psoriasis	4.49e-06	6.5e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—psoriasis	4.49e-06	6.5e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—psoriasis	4.21e-06	6.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOE—psoriasis	4.2e-06	6.07e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—psoriasis	3.91e-06	5.66e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—psoriasis	3.66e-06	5.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CAT—psoriasis	3.56e-06	5.16e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOE—psoriasis	2.77e-06	4.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—psoriasis	2.41e-06	3.49e-05	CbGpPWpGaD
